Skip to content

Clinical trials

Terminated Hepatitis B, Chronic trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Status: Terminated Country / region: Hong Kong Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20142
20151
20161
20182
20192
20204
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assembly Biosciences3
Gilead Sciences2
Hoffmann-La Roche2
Aligos Therapeutics1
Alnylam Pharmaceuticals1
Arrowhead Pharmaceuticals1
Chinese University of Hong Kong1
Enyo Pharma1
F-star Therapeutics, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic15
Hepatitis B5
Bronchiolitis Obliterans Syndrome1
Colitis, Ulcerative1
Crohn Disease1
Hepatitis1
Inflammatory Bowel Diseases1
Rheumatic Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.